In 2022, the Chinese pharmaceutical firm Innovent Biologics Inc. received revenue of **** billion yuan from customer contracts, a *** percent increase from the previous year. The core products of Innovent Biologics include anti-tumor medicines and drugs treating metabolic disorders and autoimmune diseases.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆÆ½â°æ can support your business.
Innovent Biologics. (March 28, 2023). Revenue from customer contracts of Innovent Biologics Inc. from 2019 to 2022 (in billion yuan) [Graph]. In ÌÇÐÄÆÆ½â°æ. Retrieved August 01, 2026, from /statistics/1404673/chinese-pharmaceuticals-innovent-biologics-customer-contract-revenue/
Innovent Biologics. "Revenue from customer contracts of Innovent Biologics Inc. from 2019 to 2022 (in billion yuan)." Chart. March 28, 2023. ÌÇÐÄÆÆ½â°æ. Accessed August 01, 2026. /statistics/1404673/chinese-pharmaceuticals-innovent-biologics-customer-contract-revenue/
Innovent Biologics. (2023). Revenue from customer contracts of Innovent Biologics Inc. from 2019 to 2022 (in billion yuan). ÌÇÐÄÆÆ½â°æ. ÌÇÐÄÆÆ½â°æ Inc.. Accessed: August 01, 2026. /statistics/1404673/chinese-pharmaceuticals-innovent-biologics-customer-contract-revenue/
Innovent Biologics. "Revenue from Customer Contracts of Innovent Biologics Inc. from 2019 to 2022 (in Billion Yuan)." ÌÇÐÄÆÆ½â°æ, ÌÇÐÄÆÆ½â°æ Inc., 28 Mar 2023, /statistics/1404673/chinese-pharmaceuticals-innovent-biologics-customer-contract-revenue/
Innovent Biologics, Revenue from customer contracts of Innovent Biologics Inc. from 2019 to 2022 (in billion yuan) ÌÇÐÄÆÆ½â°æ, /statistics/1404673/chinese-pharmaceuticals-innovent-biologics-customer-contract-revenue/ (last visited August 01, 2026)
Revenue from customer contracts of Innovent Biologics Inc. from 2019 to 2022 (in billion yuan) [Graph], Innovent Biologics, March 28, 2023. [Online]. Available: /statistics/1404673/chinese-pharmaceuticals-innovent-biologics-customer-contract-revenue/